269 related articles for article (PubMed ID: 15102599)
61. Efficient lentiviral transduction of Herpesvirus saimiri immortalized T cells as a model for gene therapy in primary immunodeficiencies.
Toscano MG; Frecha C; Ortega C; Santamaría M; Martín F; Molina IJ
Gene Ther; 2004 Jun; 11(12):956-61. PubMed ID: 15029233
[TBL] [Abstract][Full Text] [Related]
62. A single EBV-based vector for stable episomal maintenance and expression of GFP in human embryonic stem cells.
Thyagarajan B; Scheyhing K; Xue H; Fontes A; Chesnut J; Rao M; Lakshmipathy U
Regen Med; 2009 Mar; 4(2):239-50. PubMed ID: 19317643
[TBL] [Abstract][Full Text] [Related]
63. [Gene therapy: new developments].
Mohr L; Geissler M
Praxis (Bern 1994); 2002 Dec; 91(51-52):2227-35. PubMed ID: 12564039
[TBL] [Abstract][Full Text] [Related]
64. An enhanced EBNA1 variant with reduced IR3 domain for long-term episomal maintenance and transgene expression of oriP-based plasmids in human cells.
Wendelburg BJ; Vos JM
Gene Ther; 1998 Oct; 5(10):1389-99. PubMed ID: 9930345
[TBL] [Abstract][Full Text] [Related]
65. Genetic relationships between bovine herpesvirus 4 and the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri.
Bublot M; Lomonte P; Lequarre AS; Albrecht JC; Nicholas J; Fleckenstein B; Pastoret PP; Thiry E
Virology; 1992 Oct; 190(2):654-65. PubMed ID: 1325698
[TBL] [Abstract][Full Text] [Related]
66. Stable transduction of actively dividing cells via a novel adenoviral/episomal vector.
Leblois H; Roche C; Di Falco N; Orsini C; Yeh P; Perricaudet M
Mol Ther; 2000 Apr; 1(4):314-22. PubMed ID: 10933949
[TBL] [Abstract][Full Text] [Related]
67. Towards safe, non-viral therapeutic gene expression in humans.
Glover DJ; Lipps HJ; Jans DA
Nat Rev Genet; 2005 Apr; 6(4):299-310. PubMed ID: 15761468
[TBL] [Abstract][Full Text] [Related]
68. Retroviruses as vectors.
Vile RG; Russell SJ
Br Med Bull; 1995 Jan; 51(1):12-30. PubMed ID: 7767638
[TBL] [Abstract][Full Text] [Related]
69. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.
Bell AJ; Fegen D; Ward M; Bank A
Exp Biol Med (Maywood); 2010 Oct; 235(10):1269-76. PubMed ID: 20876083
[TBL] [Abstract][Full Text] [Related]
70. Cancer gene therapy using adeno-associated virus vectors.
Park K; Kim WJ; Cho YH; Lee YI; Lee H; Jeong S; Cho ES; Chang SI; Moon SK; Kang BS; Kim YJ; Cho SH
Front Biosci; 2008 Jan; 13():2653-9. PubMed ID: 17981740
[TBL] [Abstract][Full Text] [Related]
71. Gene therapy: promises and problems.
Pfeifer A; Verma IM
Annu Rev Genomics Hum Genet; 2001; 2():177-211. PubMed ID: 11701648
[TBL] [Abstract][Full Text] [Related]
72. Episomal viral DNA in herpesvirus saimiri-transformed lymphoid cell lines.
Werner FJ; Bornkamm GW; Fleckenstein B; Mulder C
IARC Sci Publ (1971); 1978; (24 Pt 1):125-30. PubMed ID: 221324
[TBL] [Abstract][Full Text] [Related]
73. S/MAR Element Facilitates Episomal Long-Term Persistence of Adeno-Associated Virus Vector Genomes in Proliferating Cells.
Hagedorn C; Schnödt-Fuchs M; Boehme P; Abdelrazik H; Lipps HJ; Büning H
Hum Gene Ther; 2017 Dec; 28(12):1169-1179. PubMed ID: 28665147
[TBL] [Abstract][Full Text] [Related]
74. Selectable recombinant herpesvirus saimiri is capable of persisting in a human T-cell line.
Grassmann R; Fleckenstein B
J Virol; 1989 Apr; 63(4):1818-21. PubMed ID: 2538660
[TBL] [Abstract][Full Text] [Related]
75. The latency-associated nuclear antigen homolog of herpesvirus saimiri inhibits lytic virus replication.
Schäfer A; Lengenfelder D; Grillhösl C; Wieser C; Fleckenstein B; Ensser A
J Virol; 2003 May; 77(10):5911-25. PubMed ID: 12719584
[TBL] [Abstract][Full Text] [Related]
76. Hepatocyte-specific gene expression from integrated lentiviral vectors.
Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM
J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070
[TBL] [Abstract][Full Text] [Related]
77. Lentiviral vectors for sustained transgene expression in human bone marrow-derived stromal cells.
Zhang XY; La Russa VF; Bao L; Kolls J; Schwarzenberger P; Reiser J
Mol Ther; 2002 May; 5(5 Pt 1):555-65. PubMed ID: 11991746
[TBL] [Abstract][Full Text] [Related]
78. Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS.
Johansen J; Rosenblad C; Andsberg K; Møller A; Lundberg C; Björlund A; Johansen TE
Gene Ther; 2002 Oct; 9(19):1291-301. PubMed ID: 12224012
[TBL] [Abstract][Full Text] [Related]
79. Generation of replication-competent and -defective HSV vectors.
Goins WF; Krisky DM; Wechuck JB; Wolfe D; Huang S; Glorioso JC
Cold Spring Harb Protoc; 2011 May; 2011(5):pdb.prot5615. PubMed ID: 21536761
[TBL] [Abstract][Full Text] [Related]
80. Mutation of herpesvirus Saimiri ORF51 glycoprotein specifically targets infectivity to hepatocellular carcinoma cell lines.
Turrell SJ; Whitehouse A
J Biomed Biotechnol; 2011; 2011():785158. PubMed ID: 21197456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
